| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Soligenix, Inc.
13G/A
Amendment 1
SNGX · 834223604
|
9.4% |
11/2/2026
Event 9/30/2026
|
|||
| MJL Manager LLC | 9.4% | ||||
| Michael Liu | 9.4% | ||||
| Capuchin Capital Fund LP | 9.4% | ||||
|
Arcadia Biosciences, Inc.
13G
RKDA · 039014303
|
15.7% |
9/30/2026
Event 9/25/2026
|
|||
| MJL Manager LLC | 15.7% | ||||
| Michael Liu | 15.7% | ||||
| Capuchin Capital Fund LP | 15.7% | ||||
|
Xenetic Biosciences, Inc.
13G
XBIO · 984015602
|
0% |
9/18/2026
Event 9/16/2026
|
|||
| MJL Manager LLC | 0% | ||||
| Michael Liu | 0% | ||||
|
Soligenix, Inc.
13G
SNGX · 834223604
|
5.7% |
6/25/2026
Event 6/22/2026
|
|||
| MJL Manager LLC | 5.2% | ||||
| Michael Liu | 5.7% | ||||
| Capuchin Capital Fund LP | 3.1% | ||||
|
Xenetic Biosciences, Inc.
13G
XBIO · 984015602
|
5.5% |
5/29/2026
Event 5/22/2026
|
|||
| MJL Manager LLC | 4.1% | ||||
| Michael Liu | 5.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.